Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,169,643
+$1,366,315 QoQ
Shares Held
7,645
-9.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.75%
of 13F equity value
Holder Rank
#1,307
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 18%
Shared 0%
None 82%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Core Alternative Capital holds $26,259,704 across 8 Drug Manufacturers - General names. LLY ranks #2 (34.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
37,154 | $9,436,001 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
7,645 | $9,169,643 | |
| 3 | MRK |
Merck & Co., Inc.
|
39,979 | $5,137,301 | |
| 4 | AMGN |
Amgen Inc
|
3,151 | $1,141,040 | |
| 5 | ABBV |
AbbVie Inc.
|
2,976 | $748,880 | |
| 6 | PFE |
Pfizer Inc
|
13,063 | $314,557 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,189 | $276,558 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
620 | $35,724 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,169,643 | 7,645 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $7,803,328 | 8,484 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $9,452,886 | 8,796 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $9,094,960 | 11,920 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $10,319,418 | 13,238 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $12,052,504 | 14,593 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $12,458,536 | 16,138 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $14,010,255 | 15,814 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $15,107,170 | 16,686 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $14,346,360 | 18,441 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $14,637,704 | 25,111 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $19,647,678 | 36,579 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $17,748,079 | 37,844 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $17,889,778 | 52,093 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $22,089,419 | 60,380 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $18,239,526 | 56,408 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $12,882,954 | 39,734 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $9,530,966 | 33,282 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $11,162,050 | 40,410 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $9,575,405 | 41,443 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $9,743,124 | 42,450 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $6,899,636 | 36,932 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $6,080,772 | 36,015 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $5,043,633 | 34,074 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $6,117,675 | 37,262 | Shares | Sole | 2020-07-13 | |
| 2020-03-31 | $5,692,097 | 41,033 | Shares | Sole | 2020-06-09 | |
| No filing history on record for this holder in this stock. | ||||||